BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23519216)

  • 21. Postictal agitation syndrome or anxiety symptoms.
    Swartz CM
    J ECT; 2014 Sep; 30(3):e27. PubMed ID: 25144358
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.
    Augoustides JG; Greenblatt E; Abbas MA; O'Reardon JP; Datto CJ
    J ECT; 2002 Dec; 18(4):213-7. PubMed ID: 12468998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery.
    Isik B; Arslan M; Tunga AD; Kurtipek O
    Paediatr Anaesth; 2006 Jul; 16(7):748-53. PubMed ID: 16879517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of dexmedetomidine in extreme agitation].
    Roosens E; Mulier JP; Heylens G; De Fruyt J
    Tijdschr Psychiatr; 2017; 59(9):554-558. PubMed ID: 28880357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on intracranial pressure of electroconvulsive therapy.
    Derikx RL; van Waarde JA; Verwey B; van der Mast RC
    J ECT; 2012 Jun; 28(2):e23-4. PubMed ID: 22622301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anesthetic management of a pituitary tumor resection with dexmedetomidine.
    Brady T
    AANA J; 2010 Apr; 78(2):125-8. PubMed ID: 20583457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Premedication effect of dexmedetomidine and alfentanil on seizure time, recovery duration, and hemodynamic responses in electroconvulsive therapy.
    Moshiri E; Modir H; Bagheri N; Mohammadbeigi A; Jamilian H; Eshrati B
    Ann Card Anaesth; 2016; 19(2):263-8. PubMed ID: 27052067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation.
    Hermida AP; Janjua AU; Tang Y; Syre SR; Job G; McDonald WM
    J Psychiatr Pract; 2016 Nov; 22(6):459-462. PubMed ID: 27824778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexmedetomidine: a sedative-analgesic drug for the 21st century.
    el-Tahir Kel-D
    Middle East J Anaesthesiol; 2002 Oct; 16(6):577-85. PubMed ID: 12503261
    [No Abstract]   [Full Text] [Related]  

  • 30. Additional experience with dexmedetomidine in pediatric patients.
    Tobias JD; Berkenbosch JW; Russo P
    South Med J; 2003 Sep; 96(9):871-5. PubMed ID: 14513982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation.
    Cozzi G; Lega S; Giorgi R; Barbi E
    Ann Emerg Med; 2017 Jan; 69(1):125-127. PubMed ID: 27776827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate.
    O'Mara K; Gal P; Ransommd JL; Wimmermd JE; Carlosmd RQ; Dimaguilamd MA; Davonzomd C; Smithmd M
    Ann Pharmacother; 2009 Oct; 43(10):1707-13. PubMed ID: 19755621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premedication with dexmedetomidine for prevention of hyperdynamic response after electroconvulsive therapy: a cross-over, randomized controlled trial.
    Subsoontorn P; Lekprasert V; Waleeprakhon P; Ittasakul P; Laopuangsak A; Limpoon S
    BMC Psychiatry; 2021 Aug; 21(1):408. PubMed ID: 34404384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreasing adverse outcomes of unmodified electroconvulsive therapy: suggestions and possibilities.
    Gallegos J; Vaidya P; D'Agati D; Jayaram G; Nguyen T; Tripathi A; Trivedi JK; Reti IM
    J ECT; 2012 Jun; 28(2):77-81. PubMed ID: 22531198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study.
    Akada S; Takeda S; Yoshida Y; Nakazato K; Mori M; Hongo T; Tanaka K; Sakamoto A
    Anesth Analg; 2008 Jul; 107(1):167-70. PubMed ID: 18635484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement.
    Devanand DP; Sackeim HA
    Gen Hosp Psychiatry; 1992 Sep; 14(5):345-9. PubMed ID: 1521790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexmedetomidine in the treatment of cyclic vomiting syndrome.
    Tobias JD
    Paediatr Anaesth; 2005 Aug; 15(8):709-10. PubMed ID: 16029414
    [No Abstract]   [Full Text] [Related]  

  • 38. Dexmedetomidine for the treatment of severe postoperative functional stridor.
    Bharti N
    Anaesth Intensive Care; 2012 Mar; 40(2):354-5. PubMed ID: 22417039
    [No Abstract]   [Full Text] [Related]  

  • 39. New caudal additives in children: benefit vs. risk?
    Walker SM; Yaksh TL
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1097-8; author reply 1098-9. PubMed ID: 19694618
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of Dexmedetomidine Infusion on the Recovery Profiles of Patients Undergoing Transurethral Resection.
    Kwon SY; Joo JD; Cheon GY; Oh HS; In JH
    J Korean Med Sci; 2016 Jan; 31(1):125-30. PubMed ID: 26770048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.